Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Oil up 27% in Best Month Since May

Published 11/30/2020, 04:15 PM
Updated 11/30/2020, 04:16 PM
© Reuters.

By Barani Krishnan

Investing.com - Oil prices jumped 27% or more for November, their biggest leap since the disaster of spring 2020 when crude prices tumbled into negative territory for the first time in history.

A surfeit of positive news on Covid-19 vaccines, including the possibility of Americans getting their first doses before Christmas, has fueled the remarkable rebound in oil, which fell to as low as minus $40 per barrel in April. Also underpinning the rally is the expectation that the OPEC+ producer group will halt any output hike to preserve the market momentum.

London’s Brent, the global benchmark for oil, finished the session down 30 cents, or 0.6%, at $48.18. For November, Brent rose 28%, its best month since a 95% hike in May from April’s lows.

New York-traded West Texas Intermediate, the leading indicator for U.S. crude, settled down 19 cents, or 0.4%, at $45.34 per barrel. For the month, however, WTI gained 27%, also the best recovery since May.

“WTI crude is softer for a second consecutive day but still comfortably above the $44 level as Covid-19 vaccine progress has investors pricing in a much stronger crude demand outlook for the second half of the year,”  said Ed Moya, senior market strategist at OANDA in New York.

“The tug-of-war between the short-term demand outlook with rising expectations for 2021 to deliver the return of pre-pandemic life should keep WTI crude around the mid-$40s for now.”

Oil prices have risen with little pause since mid-November after a rash of positive announcements on Covid-19 vaccine trials and therapeutics.

U.S. Health Secretary Alex Azar told a CBS interview on Monday that if all went well, Americans could get their first shots of the coronavirus vaccine before Christmas, well before any previously anticipated deadline. Azar said this after Moderna (NASDAQ:MRNA) Inc became the second drug company on Monday to apply for emergency authorization with the Food and Drug Administration to push out doses to curb the virus. 

Pfizer Inc (NYSE:PFE), which filed for similar FDA approval earlier this month, used United Airlines Holdings Inc (NASDAQ:UAL) to airlift the first mass shipment of its Covid-19 vaccines to Chicago on Friday, CNBC reported.

On the OPEC+ front, the 13-member Saudi-steered Organization of the Petroleum Exporting Countries, with 10 allies led by Russia, looked likely at a meeting on Monday to halt any further production hikes that could negate the oil rally.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.